USA Compression Partners, LP Common Units Representing Limited Partner Interests (USAC)
26.65
-1.11 (-4.00%)
USA Compression Partners LP is a publicly traded master limited partnership that specializes in providing downstream natural gas compression services
The company focuses on offering high-performance compression solutions to its clients in the oil and gas industry, primarily serving producers of natural gas and oil. With a significant portfolio of compression assets, USA Compression Partners is involved in both the rental and sales of compression equipment, ensuring efficient and reliable gas transportation and processing. The company is committed to supporting the energy sector's infrastructure needs while emphasizing operational safety, environmental responsibility, and customer satisfaction.
High-yield investments are especially attractive in today's market, where steady income can be hard to find. Energy Transfer LP (NYSEET) is a major North American midstream energy company that offers a compelling opportunity. With a 6.51% forward distribution yield and a 40% one-year performance, Energy Transfer is a potentially lucrative option for income-focused portfolios. In addition to the high yield, Energy Transfer has embarked on an ambitious growth strategy to take advantage of the energy sector's changing needs.
USAC stock results show that USA Compression Partners beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
USA Compression Partners, LP reported 18.4% revenue growth in Q4 2023, with EPS of $0.02 and net income including a $10.5 million loss. 2024 outlook includes expected growth and improved financials.
Heading into year’s end, a number of interesting stories caught my attention. Here is a brief overview of some events and regulations that may play a part in the energy space.
Investors eagerly anticipate the dividend payout from Cactus (NYSEWHD) on December 14, 2023. With a payout of $0.12 per share and an annualized dividend yield of 1.10%, this reward is exclusively for shareholders who held the stock before the ex-dividend date on November 24, 2023
Everybody loves dividends, as they provide a passive income stream and more than one way to reap a return from an investment. In addition, many have begun seeking high-yield stocks following the recent climb in treasury yields.
Gainers Bionomics Limited (NASDAQBNOX) shares jumped 308% to $4.00 after the company announced the ATTUNE trial met its primary endpoint showing BNC210 treatment led to a statistically significant reduction in total PTSD symptom severity at 12 weeks.
